However, recent findings revealed that Wnt ligands or inhibitors could affect the growth and survival of colon cancer cells in spite of the presence of APC or CTNNB1 mutations (Bafico et al, 2004; Suzuki et al, 2004; He et al, 2005). This evidence concerns the gene APC and colonic neoplasm.